Holz, F. G.
Schmitz-Valckenberg, Steffen http://orcid.org/0000-0003-3358-9942
Wolf, A.
Agostini, H.
Lorenz, K.
Pielen, A.
Feltgen, N.
Guthoff, R.
Quiering, C.
Clemens, A.
Jaeger, K.
Funding for this research was provided by:
novartis pharma gmbh nuernberg, germany.
Rheinische Friedrich-Wilhelms-Universität Bonn
Article History
Received: 22 July 2021
Revised: 24 January 2022
Accepted: 10 February 2022
First Online: 21 February 2022
Declarations
:
: The clinical study was designed and is conducted in accordance with the ethical principles laid down in the Declaration of Helsinki. The study has been approved by the ethical committee of the medical faculty of the University of Bonn.
: Written informed consent was obtained from all participants prior to study inclusion.
: Not applicable.
: FH, SS, AW, KL, AP, NF and RG received investigator fees from Novartis. AC is full time employee and shareholder of Novartis Pharma AG. CQ and KJ are full-time employees of Novartis Pharma GmbH.